Scratching the Surface of BTK Inhibition for Chronic Spontaneous Urticaria: Beyond Skin Deep

BTK inhibitors have demonstrated great promise for addressing various treatment challenges for chronic urticaria patients by improving symptom control and more effective targeting of disease pathways.
JAK is Out of the Box: Leveling Up Care for Severe Alopecia Areata Across Patient Populations

Severe alopecia areata (AA) causes a significant disease burden impacting multiple aspects of patients’ health, quality of life, and daily functioning.
Trading Steroids for Targeted Topical Therapies: Clinical Pearls for Your AD, Psoriasis, and Seborrheic Dermatitis Patients

While corticosteroids hold a valuable place in the therapeutic toolkit for atopic dermatitis, psoriasis, seborrheic dermatitis, and similar conditions, targeted topical therapies may offer better options for individualized care.